The DNMT3A gene helps place small chemical tags on DNA, which tells cells when to use certain genes. This gene helps your body guide normal growth, brain development, and blood cell production. If it does not work well, people may have overgrowth, a larger head size, and learning or developmental differences, and acquired variants in blood cells are linked to some blood cancers. Many DNMT3A variants have little or no effect.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the information needed to make proteins, the parts of cells that do much of the work. Others mainly help direct when certain processes happen, where they take place, and how strongly they are active. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
DNMT3AGene function
What if the gene works
The DNMT3A gene helps place chemical tags on DNA that control when other genes turn on or stay quiet. This supports normal growth, early development, and the way blood and other cells mature.
Risk
What if the gene does not work
Variants in the DNMT3A gene can cause overgrowth, a large head, and developmental or learning differences. Milder and severe variants can affect when features appear and how marked they are. Some variants in blood cells are linked to blood cancers.
Treatment
What does that mean for your treatment
No DNMT3A-specific treatment or management approach is currently established. Changes in the DNMT3A gene are being studied as biomarkers and possible treatment targets in acute myeloid leukemia and clonal blood conditions, but they do not currently direct routine drug choices on their own.
Conditions associated with DNMT3A
Gene function
What if the gene works
Your cells need clear timing so the right genes are active at the right moment. The DNMT3A gene helps place small chemical marks on DNA that act like notes on those instructions. Understanding what the DNMT3A gene does in your body helps explain how cells keep their identity as tissues grow and renew themselves.
The DNMT3A gene adds small chemical tags called methyl groups to DNA. These tags help cells quiet some genes and keep others ready for use.
By shaping patterns of gene activity, this gene helps each cell keep the right role after it divides. For example, a new skin cell can keep behaving like skin rather than like a different tissue.
As cells mature, the DNMT3A gene helps switch groups of genes on or off at the right time. This supports orderly development before birth and steady tissue renewal through life.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent normal genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DNMT3A gene can change the protein’s shape, stability, or ability to place chemical tags on DNA, altering how cells control gene activity. Some DNMT3A gene variants affect protein function mildly and leave partial activity, while more disruptive variants can reduce activity or create a shortened protein. Certain missense variants can interfere with the protein made from the other copy. In conditions tied to DNMT3A, this range may influence when features appear and how noticeable they are.
How variants are linked to conditions
Pathogenic variants in the DNMT3A gene are linked to a small number of well-established DNMT3A-related conditions. Inherited variants can cause Tatton-Brown-Rahman syndrome, which is associated with tall growth, a larger head size, and variable learning or developmental differences. Acquired variants that arise in blood cells are linked to clonal hematopoiesis and to a higher chance of blood cancers such as acute myeloid leukemia. Many people with an acquired DNMT3A variant never develop cancer.
A variant is not necessarily a diagnosis
Genetic variants are a common, normal part of being human and are widely seen across the general population. Most do not have a direct impact on health and instead represent natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when several genes and environmental influences are involved. In some situations, though, one well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For inherited DNMT3A changes, the chance of related health features is mainly shaped by the variant itself, not by everyday lifestyle factors. There is not enough evidence to say that diet, exercise, or other routine changes lower this genetic risk. Regular medical follow-up can still help spot concerns early and guide care.
Inheritance of DNMT3A variants
DNMT3A-related conditions are most often inherited in an autosomal dominant pattern, which means one altered copy of the DNMT3A gene can be enough to cause the condition. If a parent carries a disease-causing variant, each child has a 50% chance of inheriting it. In Tatton-Brown-Rahman syndrome, many cases happen because of a new, de novo variant, so the change was not inherited from either parent. This is the main DNMT3A inheritance pattern described in clinical genetics.
What does my DNMT3A result mean for my family?
For an inherited DNMT3A change linked to Tatton-Brown-Rahman syndrome, close relatives can sometimes have the same result, so parents, brothers, sisters, and children may also be affected or may want to consider testing. A parent with the same gene change can pass it on to each child. Some DNMT3A changes happen for the first time in one person, so a parent does not always have the same result.
Genetic information
Genetic testing
How you find out about variants
To find variants, DNMT3A genetic testing usually reads the DNA in a blood or saliva sample using sequencing, and some labs also check for missing or extra pieces of the DNMT3A gene. This shows whether a DNMT3A variant is present, absent, or still unclear.
When should I consider getting a genetic test?
Genetic testing for the DNMT3A gene may be worth considering when a child or adult has unusually fast growth, a larger-than-average head size, learning or developmental delays, and other signs of an inherited growth condition called Tatton-Brown-Rahman syndrome. It can also help when similar features run in the family.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they explain depends on the condition and the kind of variant involved. Over time, many factors influence how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts on its target. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics is an area of study focused on how differences in genes can affect the way people respond to medicines. It examines gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many drugs, genes can influence how powerfully a medication works or how the body handles it. This information can support treatment choices that are more informed and more tailored to the individual. To learn more about this topic, more information is available in the LearnHub.
Drugs influenced by the DNMT3A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so general questions about medicines or side effects are best discussed with your doctor. In blood cancers, DNMT3A changes are being studied because they may affect how some treatments work, but this has not become routine prescribing guidance.
History
The DNMT3A gene entered genetics research in the late 1990s, when scientists were identifying new genes involved in DNA methylation, a process that helps control how genes are used. Early studies placed DNMT3A alongside related genes and showed that it was part of a major shift in understanding how gene activity is regulated. From these first observations, research expanded steadily. In the 2010s, DNMT3A drew wider medical attention when variants in the gene were linked to certain blood cancers and later to Tatton-Brown-Rahman syndrome, a condition associated with tall growth and learning differences. These findings made the DNMT3A gene important not only in basic science but also in cancer genetics and developmental medicine. Today, it remains a well-known gene in epigenetics research.